Mar 2, 2023 | Press Releases, Publication
DURHAM, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) — Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal (GI) cancers, announced that the U.S. Patent and Trademark Office has issued new patent No. 11,583,576,...
Jan 19, 2022 | Press Releases, Publication
DURHAM, N.C., Jan. 19, 2022 (GLOBE NEWSWIRE) — Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, will host a virtual presentation of its poster at the American Society of Clinical Oncology’s...
Dec 6, 2021 | Press Releases, Publication
DURHAM, N.C., Dec. 06, 2021 (GLOBE NEWSWIRE) — Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces a new publication in Frontiers in Oncology, section Gastrointestinal Cancers: Gastric...
Aug 30, 2021 | Press Releases, Publication
Jill P. Smith1, Hong Cao1, Wenqiang Chen1, Bhaskar Kallakury2, Teresa Phillips3, Lynda Sutton3,and Allen Cato3 ABSTRACT The incidence of pancreatic cancer is increasing significantly and will soon become the second leading cause of cancer-related deaths in the...
Apr 13, 2021 | Press Releases
Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces that its abstract entitled, “Vaccination with Polyclonal Antibody Stimulator (PAS) prevents pancreatic carcinogenesis in the KRAS mouse...
Apr 7, 2021 | Press Releases
Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal cancers, announces that an abstract will be included in the upcoming 2021 American Association of Cancer Research (AACR) Annual Meeting being held virtually...
Recent Comments